Yayın:
Hypertension management dynamics in pediatric CKD: Insights from the 4C study

dc.contributor.authorDoyon, Anke
dc.contributor.authorBayazit, Aysun Karabay
dc.contributor.authorDuzova, Ali
dc.contributor.authorThurn, Daniela
dc.contributor.authorCanpolat, Nur
dc.contributor.authorBulut, Ipek Kaplan
dc.contributor.authorAzukaitis, Karolis
dc.contributor.authorObrycki, Lukasz
dc.contributor.authorRanchin, Bruno
dc.contributor.authorShroff, Rukshana
dc.contributor.authorCandan, Cengiz
dc.contributor.authorErdogan, Hakan
dc.contributor.authorParipovic, Dusan
dc.contributor.authorDonmez, Osman
dc.contributor.authorLugani, Francesca
dc.contributor.authorArbeiter, Klaus
dc.contributor.authorYilmaz, Ebru
dc.contributor.authorZaloszyc, Ariane
dc.contributor.authorWuhl, Elke
dc.contributor.authorMelk, Anette
dc.contributor.authorQuerfeld, Uwe
dc.contributor.authorSchaefer, Franz
dc.contributor.author4C Study Consortium
dc.contributor.buuauthorDÖNMEZ, OSMAN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridJHC-5766-2023
dc.date.accessioned2025-10-21T10:07:55Z
dc.date.issued2025-06-01
dc.description.abstractBACKGROUND: Office blood pressure (BP) trajectories may help assess hypertension progression and the effects of antihypertensive treatment in children with chronic kidney disease. METHODS: Analysis of antihypertensive treatment and BP slopes in 320 patients from the 4C study (Cardiovascular Comorbidity in Children with Chronic Kidney Disease) cohort with chronic kidney disease before renal replacement therapy, based on a minimum of 3 individual observations and 2 years of follow-up. RESULTS: At enrollment, 70 (22%) patients had uncontrolled or untreated hypertension, 130 (41%) patients had controlled hypertension, and 120 (37%) patients had normotension without antihypertensive treatment. Antihypertensive treatment medication was prescribed for 53% of patients at baseline and initiated or added for 91 patients (AHT-I [group with intensification of antihypertensive treatment] group, 28%) during follow-up. Overall BP SD score remained stable over time in the cohort (beta=-0.037 +/- 0.034, P=0.34 and -0.029 +/- 0.348, P=0.093 per year for systolic and diastolic BP SD score). In the AHT-I group, systolic and diastolic BP SD scores were higher at baseline and decreased significantly during follow-up (-0.22 +/- 0.07, P<0.003 and -0.12 +/- 0.05 SD score per year, P=0.01). Only 8 of 70 (11%) patients from the previously untreated/uncontrolled group remained untreated at the last observation, while 31 (44%) were controlled during follow-up. Of the 120 normotensive patients at baseline, 60% remained normotensive while 40% progressed to uncontrolled/untreated (n=23, 19%) or controlled (n=24, 20%) hypertension. CONCLUSIONS: Although the overall BP of the population remained stable over time, individual patterns of BP management showed considerable variability. BP control improved significantly with intensified antihypertensive therapy; however, a significant number of previously normotensive individuals developed new-onset hypertension during the observation period.
dc.identifier.doi10.1161/HYPERTENSIONAHA.124.24330
dc.identifier.endpage1045
dc.identifier.issn0194-911X
dc.identifier.issue6
dc.identifier.scopus2-s2.0-105002444857
dc.identifier.startpage1035
dc.identifier.urihttps://doi.org/10.1161/HYPERTENSIONAHA.124.24330
dc.identifier.urihttps://hdl.handle.net/11452/56364
dc.identifier.volume82
dc.identifier.wos001485547400007
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.journalHypertension
dc.subjectChronic kidney-disease
dc.subjectBlood-pressure control
dc.subjectEuropean-society
dc.subjectChildren
dc.subjectProgression
dc.subjectAntihypertensive agents
dc.subjectBlood pressure
dc.subjectChild
dc.subjectHumans
dc.subjectHypertension
dc.subjectPeripheral vascular disease
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectCardiovascular System & Cardiology
dc.titleHypertension management dynamics in pediatric CKD: Insights from the 4C study
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublicatione6367fea-0201-4aed-906e-293d0a83ef51
relation.isAuthorOfPublication.latestForDiscoverye6367fea-0201-4aed-906e-293d0a83ef51

Dosyalar